JAMA is an international peer-reviewed general medical journal published weekly online and in print, and a member of the @JAMANetwork family of journals.
💬 Perspective by Safura Abdool Karim, PhD, LLM, Ruth Faden, PhD, MPH, Chloe Searchinger, BA, and
Thomas Bollyky, JD:
The @WHO added #GLP1 receptor agonists to the Model List of Essential Medicines for diabetes, but equitable access depends on more than listing a medicine as
💬 Perspective by Francesca Celletti, MD, PhD, Jennifer Manne-Goehler, MD, PhD, Juan Victor Ariel Franco, MD, PhD, and Luz Maria De Regil, PhD: In the #GLP1 therapy era, effective care for #Obesity should combine pharmacotherapy with intensive behavioral therapy and management of
Postpartum initiation of #GLP1 receptor agonists increased among commercially insured women in the US from 2018 to 2025.
Initiation remained highest among women with #Type2Diabetes, but recent growth was also seen among women with gestational diabetes and women with overweight
US #PrescriptionDrugs launch prices increased faster than inflation from 2008 to 2025, with no evidence of a higher postpassage trend after the #InflationReductionAct.
Launch prices were higher for #CellGeneTherapy, drugs for chronic use, and drugs with rare disease
🩺 #ClinicalChallenge: A man with suspected but untreated secondary syphilis had nonscarring alopecia, photodistributed facial eruption, oral ulcers, leukopenia, and low C3 level; biopsy of a palmar lesion showed dyskeratotic keratinocytes, basal vacuolar alteration, papillary
